These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21069393)

  • 21. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
    Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
    J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular markers of early Parkinson's disease based on gene expression in blood.
    Scherzer CR; Eklund AC; Morse LJ; Liao Z; Locascio JJ; Fefer D; Schwarzschild MA; Schlossmacher MG; Hauser MA; Vance JM; Sudarsky LR; Standaert DG; Growdon JH; Jensen RV; Gullans SR
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):955-60. PubMed ID: 17215369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics analysis raises candidate genes in blood for early screening of Parkinson's disease.
    Zhang Y; Yao L; Liu W; Li W; Tian C; Wang ZY; Liu D
    Biomed Environ Sci; 2014 Jun; 27(6):462-5. PubMed ID: 24961856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
    Goldknopf IL; Park HR; Sabbagh M
    Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.
    Simuni T; Caspell-Garcia C; Coffey C; Chahine LM; Lasch S; Oertel WH; Mayer G; Högl B; Postuma R; Videnovic A; Amara AW; Marek K;
    Mov Disord; 2015 Sep; 30(10):1371-81. PubMed ID: 26095202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of polymorphisms and reduced expression levels of the NR4A2 gene with Parkinson's disease in a Mexican population.
    Ruiz-Sánchez E; Yescas P; Rodríguez-Violante M; Martínez-Rodríguez N; Díaz-López JN; Ochoa A; Valdes-Rojas SS; Magos-Rodríguez D; Rojas-Castañeda JC; Cervantes-Arriaga A; Canizales-Quinteros S; Rojas P
    J Neurol Sci; 2017 Aug; 379():58-63. PubMed ID: 28716280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher urate in LRRK2 mutation carriers resistant to Parkinson disease.
    Bakshi R; Macklin EA; Logan R; Zorlu MM; Xia N; Crotty GF; Zhang E; Chen X; Ascherio A; Schwarzschild MA
    Ann Neurol; 2019 Apr; 85(4):593-599. PubMed ID: 30761591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
    Bach JP; Gold M; Mengel D; Hattesohl A; Lubbe D; Schmid S; Tackenberg B; Rieke J; Maddula S; Baumbach JI; Nell C; Boeselt T; Michelis J; Alferink J; Heneka M; Oertel W; Jessen F; Janciauskiene S; Vogelmeier C; Dodel R; Koczulla AR
    PLoS One; 2015; 10(7):e0132227. PubMed ID: 26168044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease.
    Sutherland G; Mellick G; Sue C; Chan DK; Rowe D; Silburn P; Halliday G
    Neurosci Lett; 2007 Mar; 414(2):170-3. PubMed ID: 17280783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific splice variants are associated with Parkinson's disease.
    Santiago JA; Scherzer CR; ; Potashkin JA
    Mov Disord; 2013 Oct; 28(12):1724-7. PubMed ID: 24108702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NR4A2 genetic variation and Parkinson's disease: Evidence from a systematic review and meta-analysis.
    Liu H; Liu H; Li T; Cui J; Fu Y; Ren J; Sun X; Jiang P; Yu S; Li C
    Neurosci Lett; 2017 May; 650():25-32. PubMed ID: 28385514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of P2X7 receptor gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.
    Liu H; Han X; Li Y; Zou H; Xie A
    Neurosci Lett; 2013 Jun; 546():42-5. PubMed ID: 23648388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of potential diagnostic biomarkers for Parkinson's disease.
    Jiang F; Wu Q; Sun S; Bi G; Guo L
    FEBS Open Bio; 2019 Aug; 9(8):1460-1468. PubMed ID: 31199560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of GSK3B gene in peripheral blood in patient with Parkinson's disease].
    Filatova EV; Shadrina MI; Karabanov AV; Slominskiĭ PA; Illarioshkin SN; Ivanova-Smolenskaia IA; Limborskaia SA
    Mol Biol (Mosk); 2011; 45(3):459-63. PubMed ID: 21790007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population.
    Satoh J; Kuroda Y
    J Neurol Sci; 2001 Aug; 189(1-2):113-7. PubMed ID: 11535241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia.
    Gołab-Janowska M; Honczarenko K; Gawrońska-Szklarz B; Potemkowski A
    Neurol Neurochir Pol; 2007; 41(2):113-21. PubMed ID: 17530572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson's Disease: A Pilot Study.
    Yilmaz A; Ugur Z; Ustun I; Akyol S; Bahado-Singh RO; Maddens M; Aasly JO; Graham SF
    Cells; 2020 Oct; 9(11):. PubMed ID: 33142859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers in Parkinson's disease.
    Morgan JC; Mehta SH; Sethi KD
    Curr Neurol Neurosci Rep; 2010 Nov; 10(6):423-30. PubMed ID: 20809400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
    Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
    BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.